Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MSTU
1776
T-Rex 2X Long MSTR Daily Target ETF
MSTU
$324M
| $3.34M | ﹤0.01% |
+38,590
| New | +$2.92M |
|
1777
Red Violet
RDVT
$979M
| $3.32M | ﹤0.01% |
67,540
+48,000
| +246% | +$2.09M |
|
1778
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$304M
| $3.31M | ﹤0.01% |
94,300
-103,000
| -52% | -$3.73M |
|
1779
Helios Technologies
HLIO
$2.57B
| $3.3M | ﹤0.01% |
98,775
+36,300
| +58% | +$1.09M |
|
|
LPRO
1780
Open Lending Corp
LPRO
| $3.29M | ﹤0.01% |
1,696,925
+1,154,900
| +213% | +$1.87M |
|
1781
W.R. Berkley
WRB
$26.9B
| $3.29M | ﹤0.01% |
44,766
-289,881
| -87% | -$20.8M |
|
1782
Madrigal Pharmaceuticals
MDGL
$10.8B
| $3.28M | ﹤0.01% |
10,836
-74,250
| -87% | -$22.1M |
|
|
DCBO
1783
Docebo
DCBO
$525M
| $3.26M | ﹤0.01% |
112,631
+24,371
| +28% | +$691K |
|
|
PRSU
1784
Pursuit Attractions and Hospitality Inc
PRSU
$1.39B
| $3.25M | ﹤0.01% |
112,900
-14,700
| -12% | -$434K |
|
|
EVRI
1785
DELISTED
Everi Holdings
EVRI
| $3.25M | ﹤0.01% |
228,300
+136,500
| +149% | +$1.91M |
|
1786
Central Garden & Pet Co
CENT
$2.69B
| $3.25M | ﹤0.01% |
92,311
-8,400
| -8% | -$297K |
|
1787
International General Insurance
IGIC
$1.19B
| $3.23M | ﹤0.01% |
134,600
+50,700
| +60% | +$1.2M |
|
1788
NOV
NOV
$6.93B
| $3.23M | ﹤0.01% |
259,810
-526,000
| -67% | -$6.63M |
|
1789
Silgan Holdings
SLGN
$4.23B
| $3.23M | ﹤0.01% |
59,580
-61,800
| -51% | -$3.27M |
|
1790
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
| $3.22M | ﹤0.01% |
10,600
+4,200
| +66% | +$1.18M |
|
1791
Comp X International
CIX
$349M
| $3.22M | ﹤0.01% |
121,249
-4,600
| -4% | -$114K |
|
1792
IBEX
IBEX
$473M
| $3.2M | ﹤0.01% |
110,100
+33,500
| +44% | +$896K |
|
1793
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.66B
| $3.2M | ﹤0.01% |
52,000
+16,806
| +48% | +$982K |
|
1794
Asana
ASAN
$1.92B
| $3.2M | ﹤0.01% |
237,000
-321,600
| -58% | -$5.04M |
|
1795
IMAX
IMAX
$2.62B
| $3.19M | ﹤0.01% |
114,105
-73,595
| -39% | -$1.91M |
|
1796
Savers
SVV
$1.58B
| $3.19M | ﹤0.01% |
312,600
+156,100
| +100% | +$1.53M |
|
1797
Enerpac Tool Group
EPAC
$1.83B
| $3.18M | ﹤0.01% |
78,469
-52,500
| -40% | -$2.21M |
|
1798
Cerence
CRNC
$385M
| $3.18M | ﹤0.01% |
311,117
+167,100
| +116% | +$1.47M |
|
1799
Kulicke & Soffa
KLIC
$4.67B
| $3.17M | ﹤0.01% |
+91,728
| New | +$2.98M |
|
1800
Leggett & Platt
LEG
$1.34B
| $3.17M | ﹤0.01% |
355,300
+178,800
| +101% | +$1.54M |
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.